Global Pharmaceutical Grade Isopropyl Myristate Market Strategic Research Report
By Type: Content ≥98%, Content ≥99%
By Application: Transdermal Patches, Topical Creams/Ointments, Others
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: Croda Pharma, BASF, Musim Mas, Oleon, Inolex
概述
Scope of the Report
The global Pharmaceutical Grade Isopropyl Myristate market size is predicted to grow from US$ 14.70 million in 2025 to US$ 21.11 million in 2032; it is expected to grow at a CAGR of 5.4% from 2026 to 2032.
<p class="tw-data-text tw-text-large tw-ta" data-placeholder="翻译" id="tw-target-text" role="text" tabindex="-1" data-ved="2ahUKEwjmnJji1reRAxUKEDQIHVH-Ld8Q3ewLegQIIhAW" dir="ltr" aria-label="译文:Pharmaceutical-grade isopropyl myristate (IPM) is a colorless, oily liquid formed by the esterification of myristic acid and isopropanol. It is an excellent polar emollient, solvent, and penetration enhancer, improving the absorption and efficacy of drugs in the skin. It is widely used in transdermal formulations, ointments, creams, and other topical medications.
The upstream of its supply chain mainly consists of myristic acid and isopropanol. Myristic acid is usually derived from the decomposition of natural palm kernel oil or coconut oil, which means that the upstream supply is significantly affected by the yield of tropical oil crops and international oil and fat market prices.
The global sales volume in 2025 is estimated to be approximately 7,500 tons, with an average market price of approximately 2,000 RMB/ton. The industry"s gross profit margin is approximately 12-20%.">Pharmaceutical grade isopropyl myristate (IPM) is a colorless, oily liquid formed by the esterification of myristic acid and isopropanol. It is an excellent polar emollient, solvent, and penetration enhancer, improving the absorption and efficacy of drugs in the skin. It is widely used in transdermal formulations, ointments, creams, and other topical medications.The upstream of its supply chain mainly consists of myristic acid and isopropanol. Myristic acid is usually derived from the decomposition of natural palm kernel oil or coconut oil, which means that the upstream supply is significantly affected by the yield of tropical oil crops and international oil and fat market prices.The global sales volume in 2025 is estimated to be approximately 7,500 tons, with an average market price of approximately 2,000 RMB/ton. The industry's gross profit margin is approximately 12-20%.
Global key Pharmaceutical Grade Isopropyl Myristate players cover Croda Pharma, BASF, Musim Mas, Oleon, Inolex, etc.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pharmaceutical Grade Isopropyl Myristate market?
What factors are driving Pharmaceutical Grade Isopropyl Myristate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharmaceutical Grade Isopropyl Myristate market opportunities vary by end market size?
How does Pharmaceutical Grade Isopropyl Myristate break out by Type, by Application?
This report presents a comprehensive overview of the global Pharmaceutical Grade Isopropyl Myristate market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- Content ≥98%
- Content ≥99%
Segment by Ingredient
- Coconut Oil
- Palm Kernel Oil
Segment by Application
- Transdermal Patches
- Topical Creams/Ointments
- Others
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Pharmaceutical Grade Isopropyl Myristate market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Transdermal Patches, Topical Creams/Ointments, Others evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Pharmaceutical Grade Isopropyl Myristate Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 Content ≥98%
- 3.1.3 Content ≥99%
- 3.1.4 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Transdermal Patches
- 4.1.3 Topical Creams/Ointments
- 4.1.4 Others
- 4.1.5 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 Croda Pharma
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 BASF
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 Musim Mas
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Oleon
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 Inolex
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
What is the current global Pharmaceutical Grade Isopropyl Myristate market size?
What growth rate is expected for the Pharmaceutical Grade Isopropyl Myristate market through 2032?
How is Pharmaceutical Grade Isopropyl Myristate defined?
How is the Pharmaceutical Grade Isopropyl Myristate market segmented by type?
What are the key applications of Pharmaceutical Grade Isopropyl Myristate?
Which companies are profiled in the Pharmaceutical Grade Isopropyl Myristate market report?
What geographies does the Pharmaceutical Grade Isopropyl Myristate market analysis include?
What are the key demand drivers for Pharmaceutical Grade Isopropyl Myristate?
Who should buy the Pharmaceutical Grade Isopropyl Myristate market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Pharmaceutical Grade Isopropyl Myristate Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Pharmaceuticals